Multiple studies and reviews confirm that strategic fluorination of pharmaceutical compounds enhances their metabolic stability and pharmacokinetic profiles.
The retrieved papers consistently support the claim that fluorination improves metabolic stability in drug design, citing specific mechanisms and examples across peptides and small molecules. No papers refute the claim.